Shares of Gates-backed Vir Bio tumble after $143M IPO to fund infectious disease efforts It was a rough Wall Street debut for Vir Biotechnology, a San Francisco company with ambitious plans to battle infectious… Read More
Smartsheet files for IPO, aims to become Seattle region’s next public company Smartsheet is getting ready to go public. The Seattle-area company that helps Fortune 500 customers manage and automate key work… Read More
Alder BioPharmaceuticals aims to raise $150M to continue developing migraine prevention drug Alder BioPharmaceuticals is looking to raise approximately $150 million by selling off stock in order to continue work on a… Read More
